Oncology Nutrition Market - By Cancer Type (Head and Neck Cancers, Stomach and Gastrointestinal Cancers, Liver Cancer, Pancreatic Cancer, Esophageal Cancer, Lung Cancer, Breast Cancer, Blood Cancer, Other Cancers) By Geography (North America, Europe, Asia Pacific, Middle East & Africa Rest of the World) Industry Analysis, Opportunity and Forecast 2020 To 2027
Published Date: May 2021
No. of Pages: 183
Status: Published
Report Code: ARI100705
The significant rise in nutritional wasting and nutritional risk among cancer patients is a major factor that is anticipated to boost the growth of the oncology nutrition market during the forecast period. Participants in the current market landscape are currently investigating the potential benefits of adopting a multidisciplinary approach wherein targeted nutrition is likely to be imperative to enhance the quality of oncology care. Evolving guidelines, surge in observational studies, and growth in the number of clinical trials worldwide are some of the leading factors that are expected to propel the growth of the market for oncology nutrition in the coming years.
Nutritional screening and assessment techniques are integral to detect the identification of patients that are at a greater risk of malnourishment. Several studies have revealed that the incorporation of malnutrition screening in oncology care is expected to improve nutritional assessment and prevent malnutrition among patients. While nutritional risk continues to come under the radar, oncology nutrition is projected to gain a fair amount of momentum over the course of the assessment period. The demand for oncology nutrition is expected to further grow due to the notable surge in the adoption of nutritional assessment programs particularly during cancer cachexia and precachexia. Data collection techniques pertaining to the nutritional status of various patients have progressed at a rapid pace over the past decade. Due to these advancements, tailored oncology nutrition therapies have emerged as an ideal solution for cancer patients who are susceptible to malnutrition.
Some of the major players operating in the oncology nutrition market include FMC Corporation, Danone, Abbott Laboratories, Aceto, B. Braun Melsungen AG, Baxter International, BioSig Technologies, Fresenius Kabi AG, Global Health Products, Hansen Medical, Hormel Foods, Mead Johnson Nutrition Company, Meiji Holdings, Nestle S.A., and Victus.
Analyst Commentary
The global oncology nutrition market is expected to grow at a healthy CAGR during the forecast period. The market growth can be primarily attributed to a range of factors; including rising in the prevalence of cancer patients, technological advancements, research & development activities, and growing awareness regarding oncology nutrition are some of the leading factors that will provide an impetus to the growth of the market for oncology nutrition during the forecast period. Focus on improving nutritional assessment among cancer patients due to the rise in the number of malnutrition cases will also play an important role in boosting the growth of the oncology nutrition market.
Based on cancer type, the head and neck cancers segment accounted for the largest share of the market in 2017. Patients with head and neck cancers suffer from severe problems associated with oral nutritional intake. Thus, the enteral route is used for nutrition support. With the increasing number of such cancers cases, the uptake of tube feeding formulas has increased. Also, conditions such as severe mucositis, xerostomia, dysgeusia, and nausea & vomiting limit nutritional intake, adding to the adoption of oncology nutritional feeding formulas.
Segmentation
The oncology nutrition market is segmented based on type of cancer, and region. Based on type of cancer, the market is categorized into head & neck cancer, stomach and gastrointestinal cancers, esophageal cancer, pancreatic cancer, liver cancer, blood cancer, breast cancer, and other cancers.
Regional Analysis
The countries covered in the global oncology nutrition market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, in the Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
Among regions, North America has been witnessing a positive growth for oncology nutrition market throughout the forecasted period owing to the global leaders in research and development activities and increase incidence of cancer. In North America region, the United States holds the largest market share owing to the factors such as increasing number of populations suffering from cancer, the launch of new nutrition products, along with the rising geriatric population and developments related to cancer therapy and rising government initiative for the awareness of cancer in the country, is anticipated to further drive the oncology nutrition market in this region.
Europe is considered a second largest growing regional segment due to the presence of refined healthcare infrastructure and patient awareness level. Asia-Pacific leads the market due to the developing healthcare facilities and rise in government initiatives and specialist communities.
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Global Oncology Nutrition Market
Chapter 5. Global Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
5.1. Global Oncology Nutrition Market Share, By Cancer Type, 2015 - 2027 (USD Million)
5.1.1. Head and Neck Cancers
5.1.1.1. Market Size and Projections,2015 - 2027 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.2. Stomach and Gastrointestinal Cancers
5.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.3. Liver Cancer
5.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.4. Pancreatic Cancer
5.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.5. Oesophageal Cancer
5.1.5.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.5.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.6. Lung Cancer
5.1.6.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.6.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.7. Breast Cancer
5.1.7.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.7.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.8. Blood Cancer
5.1.8.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.8.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
5.1.9. Others
5.1.9.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.9.2. Market Size and Projections, by Region, 2015 - 2027 (USD Million)
Chapter 6. Global Oncology Nutrition Market Overview, By Geography, 2015 – 2027 (USD Million)
6.1. Global Oncology Nutrition Market Share, By Geography, 2015 - 2027 (USD Million)
6.1.1. Market Size and projections, by Countries, 2015 – 2027 (USD Million)
6.1.2. Market Share and CAGR Comparison, by Countries, 2019 (%)
Chapter 7. North America Global Oncology Nutrition Market Overview, By Countries, 2015 - 2027 (USD Million)
7.1. North America Oncology Nutrition Market Overview, 2015 - 2027 (USD Million)
7.1.1. Market size and projections, 2015 - 2027 (USD Million)
7.1.2. North America Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
7.1.3. North America Oncology Nutrition Market Overview, By Countries, 2015 - 2027 (USD Million)
7.1.3.1. U.S. Oncology Nutrition Market Overview, 2015 - 2027 (USD Million)
7.1.3.1.1. Market size and projections, 2015 - 2027 (USD Million)
7.1.3.1.2. U.S. Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
7.1.3.2. Canada Oncology Nutrition Market Overview, 2015 - 2027 (USD Million)
7.1.3.2.1. Market size and projections, 2015 - 2027 (USD Million)
7.1.3.2.2. Canada Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
7.1.3.3. Mexico Oncology Nutrition Market Overview, 2015 - 2027 (USD Million)
7.1.3.3.1. Market size and projections, 2015 - 2027 (USD Million)
7.1.3.3.2. Mexico Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
Chapter 8. Europe Global Oncology Nutrition Market Overview, By Countries, 2015 - 2027 (USD Million)
8.1. Europe Oncology Nutrition Market Overview, 2015 – 2027 (USD Million)
8.1.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.2. Europe Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
8.1.3. Europe Oncology Nutrition Market Overview, By Countries, 2015 - 2027 (USD Million)
8.1.3.1. Germany
8.1.3.1.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.3.1.2. Germany Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
8.1.3.2. France
8.1.3.2.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.3.2.2. France Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
8.1.3.3. UK
8.1.3.3.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.3.3.2. UK Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
8.1.3.4. Italy
8.1.3.4.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.3.4.2. Italy Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
8.1.3.5. Spain
8.1.3.5.1. Market size and projections, 2015 - 2027 (USD Million)
8.1.3.5.2. Spain Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
8.1.3.6. Rest of Europe
8.1.3.6.1. Market size and projections, 2015 – 2025
8.1.3.6.2. Rest of Europe Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
Chapter 9. Asia Pacific Global Oncology Nutrition Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1. Asia Pacific Oncology Nutrition Market Overview, 2015 - 2027 (USD Million)
9.1.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.2. Asia Pacific Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
9.1.3. Asia Pacific Oncology Nutrition Market Overview, By Countries, 2015 - 2027 (USD Million)
9.1.3.1. India
9.1.3.1.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.3.1.2. India Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
9.1.3.2. China
9.1.3.2.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.3.2.2. China Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
9.1.3.3. Japan
9.1.3.3.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.3.3.2. Japan Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
9.1.3.4. South Korea
9.1.3.4.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.3.4.2. South Korea Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
9.1.3.5. Rest of Asia Pacific
9.1.3.5.1. Market size and projections, 2015 - 2027 (USD Million)
9.1.3.5.2. Rest of Asia Pacific Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
Chapter 10. Middle East & Africa Global Oncology Nutrition Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1. Middle East & Africa Oncology Nutrition Market Overview, 2015 - 2027 (USD Million)
10.1.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.2. Middle East & Africa Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
10.1.3. Middle East & Africa Oncology Nutrition Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1.3.1. GCC
10.1.3.1.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.3.1.2. GCC Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
10.1.3.2. South Africa
10.1.3.2.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.3.2.2. South Africa Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
10.1.3.3. Rest of Middle East & Africa
10.1.3.3.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.3.3.2. Rest of Middle East & Africa Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
Chapter 11. South America Global Oncology Nutrition Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1. South America Oncology Nutrition Market Overview, 2015 - 2027 (USD Million)
11.1.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.2. South America Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
11.1.3. South America Global Oncology Nutrition Market Overview, By Countries, 2015- 2026 (USD Million)
11.1.3.1. Brazil
11.1.3.1.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.3.1.2. Brazil Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
11.1.3.2. Argentina
11.1.3.2.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.3.2.2. Argentina Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
11.1.3.3. Rest of South America
11.1.3.3.1. Market size and projections, 2015 – 2026
11.1.3.3.2. Rest of South America Oncology Nutrition Market Overview, By Cancer Type, 2015 - 2027 (USD Million)
Chapter 12. Competitive Landscape
12.1. Competitive environment, 2020
12.2. Strategic framework
12.2.1. Partnership/agreement
12.2.2. Expansion
12.2.3. Mergers & Acquisitions
12.2.4. New Cancer Type & Pharmaceuticals & Bioproduct development
Chapter 13. Key Player Analysis
13.1. FMC Corporation.
13.1.1. Company overview
13.1.2. Financial performance
13.1.3. Cancer Type & Pharmaceuticals & BioCancer Type Benchmarking
13.1.4. Recent initiatives
13.1.5. SWOT analysis
13.2. Danone
13.2.1. Company overview
13.2.2. Financial performance
13.2.3. Cancer Type & Pharmaceuticals & BioCancer Type Benchmarking
13.2.4. Recent initiatives
13.2.5. SWOT analysis
13.3. Abbott Laboratories.
13.4. Aceto
13.5. Braun Melsungen AG
13.6. Baxter International
13.7. BioSig Technologies
13.8. Fresenius Kabi AG
13.9. Global Health Products
13.10. Hansen Medical
13.11. Hormel Foods
13.12. Mead Johnson Nutrition Company
13.13. Meiji Holdings
13.14. Nestle S.A.
13.15. Victus
Chapter 14. Global Oncology Nutrition Market Cost Analysis
14.1. Global Oncology Nutrition Market Key Raw Materials Analysis
14.1.1. Key Raw Materials
14.1.2. Price Trend of Key Raw Materials
14.1.3. Key Suppliers of Raw Materials
14.1.4. Market Concentration Rate of Raw Materials
14.2. Proportion of Wing Cost Structure
14.2.1. Raw Materials
14.2.2. Labor Cost
14.2.3. Wing Expenses
14.3. Wing Process Analysis of Unsaturated Polyester Resin (UPR) for Composites
Chapter 15. Chain, Sourcing Strategy and Downstream Buyers
15.1. Global Oncology Nutrition Market Chain Analysis
15.2. Upstream Raw Materials Sourcing
15.3. Raw Materials Sources of Global Oncology Nutrition Market Major Manufacturers in 2019
15.4. Downstream Buyers
Chapter 16. Marketing Strategy Analysis, Distributors/Traders
16.1. Marketing Channel
16.1.1. Direct Marketing
16.1.2. Indirect Marketing
16.1.3. Marketing Channel Development Trend
16.2. Market Positioning
16.2.1. Pricing Strategy
16.2.2. Brand Strategy
16.2.3. Target Electrical Damage
16.3. Distributors/Traders List
Chapter 17. Market Effect Factors Analysis
17.1. Cancer Type & Cancer Type Progress/Risk
17.1.1. Substitutes Threat
17.1.2. Cancer Type & Cancer Type Progress in Related Industry
17.2. Oncology Needs/Customer Preference Change
17.3. Economic/Political Environmental Change
Chapter 18. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Oncology Nutrition Market share, By Cancer Type, 2020 & 2027 (%)
10. Global Oncology Nutrition Market share, By Cancer Type 2020 & 2027 (USD Million)
11. Global Oncology Nutrition Market share, by Head and Neck Cancers, By Cancer Type, 2020 & 2027 (USD Million)
12. Global Oncology Nutrition Market share, by Stomach and Gastrointestinal Cancers, By Cancer Type, 2020 & 2027 (USD Million)
13. Global Oncology Nutrition Market share, by Liver Cancer, By Cancer Type, 2020 & 2027 (USD Million)
14. Global Oncology Nutrition Market share, by Pancreatic Cancer, By Cancer Type, 2020 & 2027 (USD Million)
15. Global Oncology Nutrition Market share, by Oesophageal Cancer, By Cancer Type, 2020 & 2027 (USD Million)
16. Global Oncology Nutrition Market share, by Lung Cancer, By Cancer Type, 2020 & 2027 (USD Million)
17. Global Oncology Nutrition Market share, by Breast Cancer, By Cancer Type, 2020 & 2027 (USD Million)
18. Global Oncology Nutrition Market share, by Blood Cancer, By Cancer Type, 2020 & 2027 (USD Million)
19. Global Oncology Nutrition Market share, by Others, By Cancer Type, 2020 & 2027 (USD Million)
20. Global Oncology Nutrition Market share, by region, 2020 - 2027(%)
21. Global Oncology Nutrition Market share, by region, 2019 - 2027(USD Million)
22. North America Global Oncology Nutrition Market, 2020 - 2027(USD Million)
23. North America Global Oncology Nutrition Market share, by Countries, 2020 & 2027 (%)
24. U.S. Global Oncology Nutrition Market, 2020 - 2027(USD Million)
25. Canada Global Oncology Nutrition Market, 2020 - 2027(USD Million)
26. Europe Global Oncology Nutrition Market, 2020 - 2027(USD Million)
27. Europe Global Oncology Nutrition Market share, by Countries, 2020 & 2027 (%)
28. Spain Global Oncology Nutrition Market, 2020 - 2027(USD Million)
29. UK Global Oncology Nutrition Market, 2020 - 2027(USD Million)
30. Italy Global Oncology Nutrition Market, 2020 - 2027(USD Million)
31. Germany Global Oncology Nutrition Market, 2020 - 2027(USD Million)
32. France Global Oncology Nutrition Market, 2020 - 2027(USD Million)
33. Rest of Europe Global Oncology Nutrition Market, 2020 - 2027(USD Million)
34. Asia-Pacific Global Oncology Nutrition Market, 2020 - 2027(USD Million)
35. Asia-Pacific Global Oncology Nutrition Market share, by Countries, 2020 & 2027 (%)
36. China Global Oncology Nutrition Market, 2020 - 2027(USD Million)
37. India Global Oncology Nutrition Market, 2020 - 2027(USD Million)
38. Australia Global Oncology Nutrition Market, 2020 - 2027(USD Million)
39. Japan Global Oncology Nutrition Market, 2020 - 2027(USD Million)
40. Rest of Asia-Pacific Global Oncology Nutrition Market, 2020 - 2027(USD Million)
41. Middle East & Africa Global Oncology Nutrition Market, 2020 - 2027(USD Million)
42. Middle East & Africa Global Oncology Nutrition Market share, by Countries, 2020 & 2027 (%)
43. GCC Global Oncology Nutrition Market, 2020 - 2027(USD Million)
44. South Africa Global Oncology Nutrition Market, 2020 - 2027(USD Million)
45. Rest of Middle East & Africa Global Oncology Nutrition Market, 2020 - 2027(USD Million)
46. South America Global Oncology Nutrition Market, 2020 - 2027(USD Million)
47. Brazil Global Oncology Nutrition Market, 2020 - 2027(USD Million)
48. Mexico Global Oncology Nutrition Market, 2020 - 2027(USD Million)
49. Argentina Global Oncology Nutrition Market, 2020 - 2027(USD Million)
50. Rest Of South America Global Oncology Nutrition Market, 2020 - 2027(USD Million)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Oncology Nutrition Market, 2020-2027 (USD Million)
4. Oncology Nutrition requirement, by country, 2020-2027, (USD Million)
5. North America Oncology Nutrition Market, By Cancer Type, 2020-2027 (USD Million)
6. Europe Oncology Nutrition Market, By Cancer Type, 2020-2027 (USD Million)
7. Asia Pacific Oncology Nutrition Market, By Cancer Type, 2020-2027 (USD Million)
8. Middle East & Africa Global Oncology Nutrition Market, By Cancer Type, 2020-2027 (USD Million)
9. South America Oncology Nutrition Market, By Cancer Type, 2020-2027 (USD Million)
10. Global Oncology Nutrition Market, Company Market Share, 2018 (%)
11. FMC Corporation.: Product Benchmarking
12. FMC Corporation.: Financial Performance
13. Danone: Product Benchmarking
14. Danone: Financial Performance
15. Abbott Laboratories.: Product Benchmarking
16. Abbott Laboratories.: Financial Performance
17. Aceto: Product Benchmarking
18. Aceto: Financial Performance
19. Braun Melsungen AG: Product Benchmarking
20. Braun Melsungen AG: Financial Performance
21. Baxter International: Product Benchmarking
22. Baxter International: Financial Performance
23. BioSig Technologies: Product Benchmarking
24. BioSig Technologies: Financial Performance
25. Fresenius Kabi AG: Product Benchmarking
26. Fresenius Kabi AG: Financial Performance
27. Global Health Products: Product Benchmarking
28. Global Health Products: Financial Performance
29. Hansen Medical: Product Benchmarking
30. Hansen Medical: Financial Performance
31. Hormel Foods: Product Benchmarking
32. Hormel Foods: Financial Performance
33. Mead Johnson Nutrition Company: Product Benchmarking
34. Mead Johnson Nutrition Company: Financial Performance
35. Meiji Holdings: Product Benchmarking
36. Meiji Holdings: Financial Performance
37. Nestle S.A.: Product Benchmarking
38. Nestle S.A.: Financial Performance
39. Victus: Product Benchmarking
40. Victus: Financial Performance
The Leading Key Players in Oncology Nutrition Market
FMC Corporation
Danone
Abbott Laboratories
Aceto
B. Braun Melsungen AG
Baxter International
BioSig Technologies
Fresenius Kabi AG
Global Health Products
Hansen Medical
Hormel Foods
Mead Johnson Nutrition Company
Meiji Holdings
Nestle S.A.
Victus.
